Olanzapine Reduces Chemotherapy-induced Nausea and Vomiting Compared With Aprepitant in Myeloma Patients Receiving High-dose Melphalan Before Stem Cell Transplantation: A Retrospective Study. [electronic resource]
Producer: 20180510Description: 584-589 p. digitalISSN:- 2152-2669
- Adult
- Aged
- Algorithms
- Antiemetics -- therapeutic use
- Aprepitant
- Benzodiazepines -- therapeutic use
- Disease Management
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Induction Chemotherapy -- adverse effects
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Morpholines -- therapeutic use
- Multiple Myeloma -- complications
- Myeloablative Agonists -- administration & dosage
- Nausea -- drug therapy
- Olanzapine
- Transplantation Conditioning
- Treatment Outcome
- Vomiting -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.